{"id":"W4403312202","doi":"10.1016/j.annonc.2024.10.002","title":"Pembrolizumab plus chemotherapy for advanced and recurrent cervical cancer: final analysis according to bevacizumab use in the randomized KEYNOTE-826 study","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Bevacizumab; Pembrolizumab; Internal medicine; Oncology; Chemotherapy; Hazard ratio; Response Evaluation Criteria in Solid Tumors; Surgery; Cancer; Progressive disease; Immunotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003479935,0.001552671,0.003887413,0.0003635013,0.0003992875,0.001273452,0.0009919712,0.001219957,0.004188019],"category_scores_gemma":[0.004296625,0.000926218,0.00514439,0.0005411377,0.0007425136,0.001340351,0.000857508,0.002905634,0.0006080389],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009757083,"about_ca_system_score_gemma":0.001031428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001728373,"about_ca_topic_score_gemma":0.00421759,"domain_scores_codex":[0.9975011,0.001547465,0.0001348201,0.0003884698,0.000134688,0.0002933874],"domain_scores_gemma":[0.9983416,0.0006468521,0.0003825194,0.000222113,0.0001115678,0.0002953897],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9702064,0.0008122136,0.004971616,0.0006376645,0.01242606,0.0000426412,0.00003932006,0.0005037407,0.001705591,0.000133569,0.0006105324,0.007910716],"study_design_scores_gemma":[0.8406141,0.06268576,0.0516858,0.0002106924,0.03797317,0.0001193625,0.0001260395,0.001991108,0.0009983819,0.0008744186,0.002633632,0.00008755367],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848873,0.009042221,0.0009904034,0.0004223068,0.0004139856,0.0008937608,0.001562802,0.00005810939,0.00172915],"genre_scores_gemma":[0.993004,0.001620568,0.0008093921,0.0005608699,0.0001967447,0.0005398964,0.001577416,0.00002444271,0.001666562],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004188019,"threshold_uncertainty_score":0.01840383,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1376732737929899,"score_gpt":0.4595266413385656,"score_spread":0.3218533675455757,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}